Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial

  1. Orkin, C.
  2. Molina, J.-M.
  3. Negredo, E.
  4. Arribas, J.R.
  5. Gathe, J.
  6. Eron, J.J.
  7. Van Landuyt, E.
  8. Lathouwers, E.
  9. Hufkens, V.
  10. Petrovic, R.
  11. Vanveggel, S.
  12. Opsomer, M.
  13. Ajana, F.
  14. Arribas, J.R.
  15. Bailey, J.
  16. Benson, P.
  17. Berenguer, J.
  18. Bhatti, L.
  19. Blaxhult, A.
  20. Brar, I.
  21. Bredeek, U.F.
  22. Brinson, C.
  23. Brunetta, J.
  24. Casado, J.
  25. Clarke, A.
  26. Conway, B.
  27. Cotte, L.
  28. Crofoot, G.
  29. Cunningham, D.
  30. de Vente, J.
  31. De Wit, S.
  32. DeJesus, E.
  33. Dietz, C.
  34. Dretler, R.
  35. Eron, J.
  36. Fehr, J.
  37. Felizarta, F.
  38. Fichtenbaum, C.
  39. Flamholc, L.
  40. Florence, E.
  41. Galindo, M.J.
  42. Gallant, J.
  43. Gasiorowski, J.
  44. Gatell, J.M.
  45. Gazzard, B.G.
  46. Girard, P.-M.
  47. Gisslèn, M.
  48. Gutierrez, F.
  49. Gutierrez, M.D.M.
  50. Hagins, D.
  51. Halota, W.
  52. Henn, S.
  53. Henry, W.K.
  54. Horban, A.
  55. Huhn, G.
  56. Iribarren, J.A.
  57. Jain, M.
  58. Johnson, M.A.
  59. Katlama, C.
  60. Klein, M.
  61. Knobel, H.
  62. Lucasti, C.
  63. Martorell, C.
  64. McDonald, C.
  65. Mills, A.
  66. Molina, J.-M.
  67. Morales-Ramirez, J.
  68. Mounzer, K.
  69. Moutschen, M.
  70. Murphy, D.
  71. Nahass, R.
  72. Negredo, E.
  73. Olivet, H.
  74. Osiyemi, O.
  75. Perez-Valero, I.
  76. Piekarska, A.
  77. Pineda, J.A.
  78. Podzamczer, D.
  79. Poizot-Martin, I.
  80. Portilla Sogorb, J.
  81. Post, F.
  82. Prelutsky, D.
  83. Pulido, F.
  84. Rachlis, A.
  85. Raffi, F.
  86. Ramgopal, M.
  87. Rashbaum, B.
  88. Rauch, A.
  89. Rey, D.
  90. Reynes, J.
  91. Ricart, C.
  92. Richmond, G.
  93. Rivero, A.
  94. Ruane, P.
  95. Gil, I.S.
  96. Scarsella, A.
  97. Scribner, A.
  98. Shafran, S.
  99. Shalit, P.
  100. Shamblaw, D.
  101. Slim, J.
  102. Stoeckle, M.
  103. Tashima, K.
  104. Teicher, E.
  105. Thalme, A.
  106. Ustianowski, A.
  107. Van Wijngaerden, E.
  108. Vandekerckhove, L.
  109. Vandercam, B.
  110. Voskuhl, G.
  111. Walmsley, S.
  112. Ward, D.
  113. Waters, L.
  114. Wilkin, A.
  115. Witor, A.
  116. Yazdanpanah, Y.
  117. Mostrar todos los/as autores/as +
Revista:
The Lancet HIV

ISSN: 2352-3018

Año de publicación: 2018

Volumen: 5

Número: 1

Páginas: e23-e34

Tipo: Artículo

DOI: 10.1016/S2352-3018(17)30179-0 GOOGLE SCHOLAR